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Abstract
Background: The evolutionary mechanisms structuring the expression pattern of variant surface antigen (VSA) families that
allow pathogens to evade immune responses and establish chronic and repeated infections pose major challenges to
theoretical research. In Plasmodium falciparum, the best-studied VSA family is erythrocyte membrane protein 1 (PfEMP1).
Each parasite genome encodes about 60 PfEMP1 variants, which are important virulence factors and major targets of host
antibody responses. Transcriptional switching is the basis of clonal PfEMP1 variation and immune evasion. A relatively
conserved subset of PfEMP1 variants tends to dominate in non-immune patients and in patients with severe malaria, while
more diverse subsets relate to uncomplicated infection and higher levels of pre-existing protective immunity.
Methodology/Principal Findings: Here, we use the available molecular and serological evidence regarding VSAs, in
particular PfEMP1, to formulate a mathematical model of the evolutionary mechanisms shaping VSA organization and
expression patterns. The model integrates the transmission dynamics between hosts and the competitive interactions
within hosts, based on the hypothesis that the VSAs can be organized into so-called dominance blocks, which characterize
their competitive potential. The model reproduces immunological trends observed in field data, and predicts an
evolutionary stable balance between inter-clonally conserved dominance blocks that are highly competitive within-host
and diverse blocks that are favoured by immune selection at the population level.
Conclusions/Significance: The application of a monotonic dominance profile to VSAs encoded by a gene family generates
two opposing selective forces and, consequently, two distinct clusters of genes emerge in adaptation to naı ¨ve and partially
immune hosts, respectively.
Citation: van Noort SP, Nunes MC, Weedall GD, Hviid L, Gomes MGM (2010) Immune Selection and Within-Host Competition Can Structure the Repertoire of
Variant Surface Antigens in Plasmodium falciparum - A Mathematical Model. PLoS ONE 5(3): e9778. doi:10.1371/journal.pone.0009778
Editor: James G. Beeson, Walter and Eliza Hall Institute of Medical Research, Australia
Received November 23, 2009; Accepted February 19, 2010; Published March 22, 2010
Copyright:  2010 van Noort et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was funded by Fundacion para a Ciencia e a Tecnologia (FCT) and the European Commission (grants MEXT-CT-2004-14338 and EC-ICT-
231807 (EPIWORK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: vnoort@igc.gulbenkian.pt
Introduction
Although people living in malaria endemic regions typically
carry Plasmodium falciparum parasites throughout life, clinical
symptoms decrease markedly with age [1]. Naturally acquired
immunity to the disease involves many components and their
relative importance is only partially understood [2]. However,
antibodies undoubtedly form a critical component of immunity to
the asexual blood stages [3], and the parasite-encoded variant
surface antigens (VSAs) exported to the surface of infected
erythrocytes (IEs) are important targets [4,5]. P. falciparum parasites
possess several VSA families, of which the best characterized is P.
falciparum erythrocyte membrane protein 1 (PfEMP1) encoded by
approximately 60 var genes per genome [6]. The level of diversity
among var genes varies greatly both between and within individual
genomes [7]. PfEMP1 variants mediate adhesion of IEs to
different host endothelial receptors, and different binding
properties have been associated with distinct patterns of
sequestration and pathogenesis [8]. The importance of PfEMP1
in malaria pathogenesis has motivated the development of
theoretical models of diversity and immune selection [9–11].
Individual IEs express only a single PfEMP1 variant at a time
[12]. Early in blood stage infection after liver release, many var
genes are transcribed by the various IEs, but gradually this pattern
changes and particular subsets of var genes are predominantly
expressed [13,14], while others may still be expressed at low
frequency due to transcriptional switching [15,16]. Variants that
predominate in the early phase of infection probably have higher
effective multiplication rates (possibly due to more efficient
endothelial sequestration rates) or higher on-switching rates. In
any case, the history of PfEMP1 expression is recorded in the
antibody repertoires that accumulate in individual hosts, regardless
of the molecular basis of the sequence of expression [4,17–19].
There is evidence that there is a threshold of PfEMP1
expression necessary for induction of an immune response [20].
If so, low-level or heterogeneous expression of PfEMP1 variants,
such as in the early stages of infection, might not be sufficient to
induce immunity. As the immune system disables IEs expressing
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parasites expressing an antigenically distinct VSA will come to
dominate the infection [21]. When a VSA is no longer expressed,
antibody levels against it decrease, but immunological memory
persists and antibody levels can be rapidly restored upon re-
exposure [22–24].
Here we investigate the role of variation in adhesion properties
and cumulative antibody repertoires in selecting for the observed
patterns in expression [25,26]. Integrating these individual-level
processes into a mathematical model of P. falciparum transmission,
we refine the requirements for the emergence of realistic variation
in VSA expression at the population level. The model allows for
multiple genotype infections, encapsulating a form of within-host
competition that gives selective advantage to parasites expressing
more dominant VSAs [27].
Although global var gene diversity is immense [28], there is
increasing evidence that there exist restricted subgroups of
antigenically similar VSAs that have a selective advantage in
naive hosts and are associated with severe disease (called ‘‘high-
dominance’’ VSAs here), whereas other more diverse PfEMP1
variants (called ‘‘low-dominance’’ VSAs) are more common in the
uncomplicated and sub-clinical infections of more immune hosts
[26,29–35]. Our model suggests that within-host competition
selects for a relatively conserved repertoire of high-dominance
VSAs, while a diverse repertoire of low-dominance forms is
maintained by their ability to remain unrecognised by host
immunity for extended periods allowing chronicity of infections.
We propose this mechanism of two-level selection as an
evolutionary explanation for the subdivision of large VSA families
such as PfEMP1.
Results
Model outline
On the basis of available experimental evidence summarized
above, we hypothesize that the global repertoire pool of variants
within a given VSA family can be ordered into a dominance
hierarchy that determines the order in which they are expressed in
an infection. The dominance hierarchy is considered the
aggregated result of a variety of selective factors, including
adhesion avidity, receptor availability, metabolic cost, gene
switching rates, and immuno-dominance, to name a few. The
parasites in an infection will therefore tend to express the most
dominant variant to which the host does not have pre-existing
immunity. As immunity to the initially dominant variant is
acquired, continued parasite survival depends on the ability to
switch away from this variant, and switching back to the originally
expressed variant will be unsuccessful as long as protective levels of
antibody with specificity for this variant persist.
Before constructing a model we must devise a scheme to
aggregate the immense VSA diversity in a way that is both
biologically meaningful and mathematically tractable. As we are
mainly interested here to explore host population-level processes,
we define ‘‘dominance blocks’’ as groupings of undefined numbers
of consecutive variants. Since dominance reflects preferential
expression, it is assumed here that antigenic switching during a
single infection occurs among consecutive variants within a
dominance block, and is therefore not visible at the scale of
blocks. Dominance blocks are thus a convenient unit for the
construction of transmission models at this level.
Estimates of the duration of a P. falciparum infection are in the
order of 200 to 700 days [36–38], with peaks in parasitaemia every
20–25 days [39]. If peaks in parasitaemia correspond to clonal
replacement of one variant by another, and in the absence of
substantial cross-reactive immunity among intraclonal variants
[40], between eight (an infection that lasts 200 days with peaks
every 25 days) and 35 (peaks every 25 days of a 700 day infection)
different VSAs can be assumed to be expressed in the course of an
untreated monoclonal infection. This collection of VSAs corre-
sponds to a dominance block. The model will be formulated in
terms of blocks of VSAs, indexed such that a lower index
represents a higher dominance (Fig. 1a, top). Each parasite can
thus be assumed to possess between approximately two (at 35
variants per block) and seven (at eight variants per block)
dominance blocks of a given VSA family such as the 60-member
PfEMP1 family, and should therefore be able to re-infect a given
host at least a corresponding number of times (each time
expressing variants from a new block) before all family members
have been expressed (Fig. 1a, middle). In reality, the number may
well be higher, as levels of variant-specific antibodies often decline
fairly rapidly once exposure to the variant ceases [22–24].
Multiple-clone infections are very common in malaria endemic
areas. We hypothesize that VSA dominance not only determines
the order of VSA expression of a single clonal lineage, but also the
dynamics of multiple-clone infections. When an already infected
host is exposed to a new parasite, we assume that the transmission
potential of the invader in relation to the resident increases with
the dominance difference between the respective VSAs. Others
[41] have shown that such weighted processes can be mathemat-
ically simplified while maintaining the essence of the model
dynamics, by assuming the polarized view that the invader
replaces the resident parasite (superinfection) with a probability s
(Fig. 1a) and is cleared otherwise. The probability s is formally
defined as a function of the difference between the dominance
blocks expressed by invader and resident parasites (Fig. 1b).
As hosts in the population gradually acquire immunity to
individual dominance blocks, they remain susceptible only to
parasites which express blocks of lower dominance (Fig. 1c). A
correlation between dominance and disease severity is implicit in
the model, and is used to evaluate its performance. Immunity to
specific VSA blocks wanes over time. The mathematical formalism
of the model is provided in the Methods section.
Model simulations
We will describe equilibrium results from simulations of model
realisations where parasites are described by four dominance
blocks drawn from a pool of seven. This greatly simplifies the
description of the model output but retains the generality of the
model performance.
The vast majority of hosts without any pre-existing VSA-specific
antibodies is predicted by the model to be infected by parasites
expressing VSAs belonging to dominance block 1. As host
repertoires of VSA-specific antibodies broaden, the probability
that their infections will be dominated be parasites expressing
VSAs from dominance blocks lower in the hierarchy increases,
and the ability to predict which block is expressed in a given host
decreases (Fig. 2A). If we associate high-dominance VSAs with
more severe forms of malaria, and note that the antibody
repertoire broadens with age, this output fits the observations
that overall malaria severity decreases with age in endemic areas
[1], and that low immunity and young age are associated with
infections dominated by serologically similar VSAs, whereas VSA
expression in older, more immune individuals with uncomplicated
infections is much more diverse [26,29]. The host’s capacity to
clear an infection before exhausting the VSA repertoire of the
infecting parasite (see Model outline above) and the non-random
sequential expression of variants from high- to low-dominance,
furthermore leads the model to predict a population-level gradient
VSA Selection
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dominance VSAs to low prevalence of hosts with antibodies
against low-dominance VSAs (Fig. 2B). The model also predicts a
negative correlation between the size of the antibody repertoire
and the seroprevalence against the expressed VSA, meaning that
VSAs expressed in hosts with broad antibody repertoires are less
recognized in the host population than VSAs expressed in hosts
with narrow antibody repertoires (Fig. 2C). The trends in Fig. 2B,C
correspond well with field data [25,26,42].
The model predicts that the high prevalence of antibodies with
specificity for dominant VSAs favours parasites encoding low-
dominance variants while parasites encoding the high-dominance
variants are simultaneously favoured because of their ability to
superinfectanddisplaceresidentparasitesfrominfectedhosts(Fig.3,
solid red line). These opposing selective forces shape the parasite
population such that a typical parasite genome will contain VSAs
from both high- and low-dominance VSAs, while variants of
intermediate dominance will be the least frequent in the parasite
population. Indeed, the selection for high-dominance VSAs
becomes weaker when the ability to superinfect is removed from
the model, while assigning only a single VSA block to each parasite
weakens the selection for low-dominance VSAs. Parasite genomes
encoding multiple copies of the same VSAs are outcompeted by
parasite genomes encoding the maximum number of distinct VSAs,
consistent with high inter-locus diversity seen in the genome [6].
Finally, we explore the dependence of VSA distributions on the
size of the available pool of variants. By increasing the size of the
VSA pool from 5 to 8 blocks, the model predicts that the
prevalence of high-dominance VSAs is essentially independent on
the global size of the pool, while low dominance VSAs tend to
become more heterogeneously distributed throughout the parasite
population (Fig. 4). In reality, the number of antigenically distinct
VSAs, and thereby the number of possible dominance blocks, is
likely to be very large, leading to a restricted set of highly
dominant and serologically similar VSAs, and a much larger set of
serologically diverse VSAs each with low prevalence.
Discussion
Immunity to malaria following natural exposure to P. falciparum is
developed over several to many years, and sterile immunity is
probably never achieved. However, immunity to severe disease
develops much faster than protection from uncomplicated disease
and asymptomatic parasitaemia [43]. It has been suggested that this
epidemiological pattern is due to the importance of VSA-specific
immunity for clinical protection, to the non-random order in which
immunity to specific VSAs is acquired, and to the association
between particular VSAs with specific disease syndromes [5,44].
We present a mathematical model which implements the
interplay between two opposing selection pressures; one that favours
virulent (high-dominance) VSAs in non-immune hosts, the other
facilitating non-virulent (low-dominance) VSAs that allow chronic
infections in individuals with substantial VSA-specific immunity.
Our results complement previous models that have addressed
expression patterns [10,45] and acquisition of immunity [46].
We introduce the concept of dominance blocks to describe the
competitive interactions among the different VSAs of a single
parasite (intra-clonal variation) and among the VSAs of different
Figure1. Schematic representation of infection dynamics. (A) VSAvariants are organized into dominance blocks, where dominance ranges from
thehighest(VSA block1)tothelowest(VSA blockn)(A,topl).Each parasitegenotypecontainsVSAs from afixednumber ofVSAblocks. Ina naivehost,a
parasite clone (illustrated by a set of 3 VSA blocks) expresses VSAs from the most dominant block. Immunity is illustrated by an antibody and expression
by a star. The host mounts an immune response to the expressed VSAs and eventually the infection is cleared. On a subsequent infection the host is
already immune to VSAs from previously expressed blocks, leading to the expression of VSAs belonging to the next most dominant VSA block (A,
middle). When an infected host is exposed to a new parasite which encodes VSAs from a more dominant block, the resident parasite can be replaced
with a probability s (A,bottom). (B) Implementationof dominance hierarchyof 7 VSAblocks, such that s1,4is theprobability of superinfection when VSA
block 1 invades a host with a resident parasite expressing VSA block 4. (C) Heterogeneous immune repertoires among hosts. Hosts acquire specific
immunity with exposure, represented by colours matching VSA blocks in previous panels. The immune repertoire may contain gaps if a host has not
been exposed to a particular variant block. Fewer hosts are susceptible to VSA 1 (small dashed circle) than to VSA 7 (large dashed circle).
doi:10.1371/journal.pone.0009778.g001
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expression,withinand between hosts, all followfrom thedominance
hierarchy. The preferential expression of high-dominance VSAs in
naive hosts leads to host immunity and quickly exhaust the pool of
susceptible hosts available to them. Low-dominance VSAs, on the
other hand, allow persistent infections and thereby ensure efficient
transmission from host to host. The ability of parasites encoding
high-dominance VSAs to superinfect, favours their conservation.
The output of our model is compatible with field observations.
The existence of different levels of immune selection acting on
VSAs has been suggested through the application of network
approaches to serological data [11]. It is reinforced here with a
model that is the first to combine intra-host competition and inter-
host transmission to investigate the combined effects of selection at
multiple levels. The model suggests a mechanism for the observed
structuring of VSA into distinct clusters, reproducing important
features of serological observations from the field. Although the
results are general, it would be interesting to investigate how they
might be modulated by transmission intensity and cross-immunity.
Molecular studies have shown that var genes, previously
classified into five major groups (A–E), could be organized into
two broad clusters [35,47]. A relatively conserved cluster consists
of restricted subsets of structurally related variants transcribed by
parasites obtained from individuals with limited or no immunity
preferentially transcribe [14,48], and parasites selected in vitro for
reactivity of IEs with IgG from children with limited immunity
[49]. Transcription of two of these subsets (Group A and Group
B/A) has repeatedly been associated with severe disease [30–34].
A much more diverse cluster contains Group C which has been
largely associated with asymptomatic infections [31].
Figure 2. Expression and seroprevalence of VSAs at endemic equilibrium. (A) VSA expression within hosts with different levels of past
exposure (measured by host antibody repertoire). (B) Seroprevalence for the different VSA blocks (trend displayed in Fig. 3 of [29]). (C) Seroprevalence
for the expressed VSA as a function of host antibody repertoire (trend displayed in Fig. 2c of [42]).
doi:10.1371/journal.pone.0009778.g002
Figure 3. Frequency distributions of VSAs in the parasite population at endemic equilibrium. Opposing selection pressures favour VSA
blocks at each end of the dominance hierarchy (solid red line), suggesting a mechanism behind the two clusters displayed in Fig. 3 of [35].
Superinfection selects for high-dominance VSAs (compare solid red line and dotted blue line). When parasites contain multiple VSA blocks, acquired
immunity selects for low-dominance variants (compare solid red line and dotted green line). Without superinfection and only a single VSA block per
parasite, there is no frequency difference between the different VSA blocks (dotted yellow line).
doi:10.1371/journal.pone.0009778.g003
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that might be driving the evolution of separate clusters of VSAs, as
seen for the var gene subfamilies of P. falciparum. The hypothesis
predicts a restricted subset of high-dominance VSAs associated
with severe malaria, and genetically and immunologically diverse
low-dominance VSAs related to uncomplicated and asymptomatic
infection.
Methods
The model, constructed as a system of ordinary differential
equations, integrates dynamics at two levels (pathogen competition
at the individual level as immunological memory accumulates, and
pathogen transmission at the population level) in a form that is
inevitably dense. In the interest of clarity we construct the model
in a stepwise manner.
Parasites with a single dominance block
We write a first version where each parasite in characterised by
only one dominance block, and then generalise for multiple
blocks. Consider a pathogen population comprising a diversity of
VSA blocks, indexed by the set N~ 1,2,...,n fg ,o r d e r e db y
inverse dominance. Hosts are classified into uninfected (S)o r
infected (I) and by the subset of blocks to which they have
immunological memory (h). Infected hosts are further classified
by the blocks that they are currently infected with (p). This system
is written as
dSh
dt
~
X
h~~ h hzq1
cI
~ h h
q1
{
X
q2= [h
lq2Shzmdh~w
{mShzWS h   
, for all h5N
dIh
p
dt
~lpSh{ czm ðÞ Ih
pzWI h
p
  
zXI h
p
  
, for all h5N,p6[h
ð1Þ
where q1 indicates the VSA block by which the host was
previously infected while having immunological memory ~ h h, q2
indicates the VSA block by which the susceptible host will be
infected, c i st h er a t eo fr e c o v e r yf r o mi n f e c t i o n ,m is the rate of
birth and death, dh~w is a delta function indicating that
individuals have no immunity at birth, lp~
P
p= [h bIh
p is the
force of infection of variant p,a n dW and X are functions that
determine waning immunity (2) and superinfection (3), respec-
tively. For simplicity of notation, we write hzp,i n s t e a do f
hz p fg ,e v e nt h o u g hh is a set and p is an element.
Waning immunity is implemented as
WS h   
~
X
q1= [h
aS
hzq1{
X
q2[h
aSh
WI h
p
  
~
X
q1= [h
aI
hzq1
p {
X
q2[h
aIh
p:
ð2Þ
where q1 indicates the VSA block for which the host previously
had immunity, and q2 indicates the VSA block for which the host
is losing immunity.
Superinfection is implemented such that hosts currently infected
by a block, p, can be superinfected by a higher dominance block,
q2, with a force of infection sq2plq2. By superinfection, we mean
that hosts become infectious with the new block while the old
variant is cleared and added to the repertoire of immunological
memory. This is formalised as
XI h
p
  
~
X
h~~ h hzq1
p= [~ h h
spq1lpI
~ h h
q1
{
X
q2= [h
sq2plq2Ih
p, ð3Þ
where q1 indicates the VSA block by which an infected host was
previously infected while having immunological memory ~ h h. The
coefficient sq2p (and equivalently spq1) is defined such that the rate
of superinfection increases with the difference in dominance
Figure 4. Frequency distributions of VSAs at endemic equilibrium for increasing sizes of the global pool. Increasing the size of the
global pool leaves the frequency of high-dominance VSAs unchanged, and diversity accumulates among the low-dominance VSAs. The frequency
distribution for a global pool of 7 blocks is also shown in Fig. 3 (solid red line).
doi:10.1371/journal.pone.0009778.g004
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sq2p~
1
q2
{
1
p
,i f q2vp
0, otherwise:
8
<
:
ð4Þ
Parasites with multiple dominance blocks
The system is readily generalisable to a scheme where each
parasite is characterised by multiple VSA blocks. Consider a
parasite, p~ v1,v2,...,vm ðÞ , characterized by m blocks drawn from
a pool N~ 1,2,...,n fg and ordered by inverse dominance. Upon
infection by a parasite, p, a host with immunological memory, h,
will express the most dominant block for which the host does not
have immunity, n~min(p\h). The system is written as
dSh
dt
~
X
h~~ h hzv1
v1~min q1,~ h h ðÞ
cI
~ h h
q1
{
X
q265h
lq2Shzmdh~w
{mShzWS h   
, for all h5N
dIh
p
dt
~lpSh{ czm ðÞ Ih
pzWI h
p
  
zXI h
p
  
, for all h5N,p 65h
ð5Þ
where q1 indicates a parasite expressing VSA block n1 by which the
susceptible host was previously infected while having immunolog-
ical memory ~ h h, q2 indicates the parasite by which a susceptible host
will be infected, and lp~
P
p65h bIh
p is the force of infection of
parasite p. Waning immunity is implemented as
WS h   
~
X
v1= [h
aS
hzv1{
X
v2[h
aSh
WI h
p
  
~
X
v1= [h,v1= [p
aI
hzv1
p {
X
v2[h,v2= [p
aIh
p,
ð6Þ
where n1 indicates the VSA block for which the host previously
had immunity, and n2 indicates the VSA block for which the host
is losing immunity.
Superinfection is determined by
XI h
p
  
~
X
h~~ h hzn1
v~min p\h ðÞ
n1~min q1\~ h h ðÞ
svn1lpI
~ h h
q1
{
X
q265h
v~min p\h ðÞ
n2~min q2\ hzv ðÞ ðÞ
sn2vlq2Ih
p, ð7Þ
where q1 indicates the parasite expressing VSA block n1 by which the
host was previously infected while having immunological memory ~ h h,
and q2 indicates the parasite expressing VSA block n2 by which the
host will be superinfected, The coefficients s are as in (4).
The principal steps in this process are represented diagram-
matically in the Supporting Information (Figure S1). The
parameters describing the rates of transition between compart-
ments take values in accordance with previous studies (Aguas et al
2008): birth and death (m~1=50); recovery from infection (c~6);
loss of immunity (a~0:8); transmission (b~10). The time unit is
one year.
Supporting Information
Figure S1 Model diagram
Found at: doi:10.1371/journal.pone.0009778.s001 (0.09 MB
PDF)
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